open access

Vol 67, No 6 (2016)
Original papers
Published online: 2016-01-27
Submitted: 2015-11-30
Accepted: 2016-01-12
Get Citation

Is galectin-3 associated with urinary albumin excretion in type 2 diabetes?

Nihal Yücel, Özlem Çakır Madenci, Aycan Bölük, Lale Köroğlu Dağdelen, Yusuf Temel, Mehmet Sargın, Asuman Orçun
DOI: 10.5603/EP.a2016.0036
·
Endokrynologia Polska 2016;67(6):580-584.

open access

Vol 67, No 6 (2016)
Original papers
Published online: 2016-01-27
Submitted: 2015-11-30
Accepted: 2016-01-12

Abstract

Introduction: The relationship between galectin-3 and diabetes mellitus or renal function has recently been investigated. In this study, we tried to evaluate the association of galectin-3 in urinary albumin excretion levels in type 2 diabetic patients.

Material and methods: In a group of 137 type 2 diabetes patients, the mean of the last three urinary microalbumin/creatinine ratios and galectin-3 levels were evaluated. The patient group was divided into three subgroups according to their level of albuminuria calculated with urine microalbumin/creatinine ratio.

Results: There was no significant difference between the galectin values of the three subgroups. Significant differences were observed between GFR results of group 1 vs. 3 (p < 0.0001) and group 2 vs. 3 (p = 0.0006), and serum creatinine results of group 1 vs. 3 (p = 0.0003) and group 2 vs. 3 (p < 0.0001). The three subgroups did not reveal any significant difference concerning the age, BMI, duration of DM, FPG, and HbA1c levels.

Conclusions: We concluded that serum galectin-3 values are not affected by the levels of urinary albumin excretion in DM patients. We could not find any relation between galectin-3 and the parameters of DM such as FPG, HbA1c, and duration of the disease. (Endokrynol Pol 2016; 67 (6): 580–584)

Abstract

Introduction: The relationship between galectin-3 and diabetes mellitus or renal function has recently been investigated. In this study, we tried to evaluate the association of galectin-3 in urinary albumin excretion levels in type 2 diabetic patients.

Material and methods: In a group of 137 type 2 diabetes patients, the mean of the last three urinary microalbumin/creatinine ratios and galectin-3 levels were evaluated. The patient group was divided into three subgroups according to their level of albuminuria calculated with urine microalbumin/creatinine ratio.

Results: There was no significant difference between the galectin values of the three subgroups. Significant differences were observed between GFR results of group 1 vs. 3 (p < 0.0001) and group 2 vs. 3 (p = 0.0006), and serum creatinine results of group 1 vs. 3 (p = 0.0003) and group 2 vs. 3 (p < 0.0001). The three subgroups did not reveal any significant difference concerning the age, BMI, duration of DM, FPG, and HbA1c levels.

Conclusions: We concluded that serum galectin-3 values are not affected by the levels of urinary albumin excretion in DM patients. We could not find any relation between galectin-3 and the parameters of DM such as FPG, HbA1c, and duration of the disease. (Endokrynol Pol 2016; 67 (6): 580–584)

Get Citation

Keywords

galectin-3; type 2 diabetes mellitus; nephropathy

About this article
Title

Is galectin-3 associated with urinary albumin excretion in type 2 diabetes?

Journal

Endokrynologia Polska

Issue

Vol 67, No 6 (2016)

Pages

580-584

Published online

2016-01-27

DOI

10.5603/EP.a2016.0036

Bibliographic record

Endokrynologia Polska 2016;67(6):580-584.

Keywords

galectin-3
type 2 diabetes mellitus
nephropathy

Authors

Nihal Yücel
Özlem Çakır Madenci
Aycan Bölük
Lale Köroğlu Dağdelen
Yusuf Temel
Mehmet Sargın
Asuman Orçun

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl